The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat
about
Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308Similar decrease in spontaneous morphine abstinence by methadone and RB 101, an inhibitor of enkephalin catabolismBrain and gastrointestinal cholecystokinin receptor family: structure and functional expressionThe roles of nerve growth factor and cholecystokinin in the enhancement of morphine analgesia in a rodent model of central nervous system inflammationPD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexesCholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependenceAssociation of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction.CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat.Novel peptide ligands with dual acting pharmacophores designed for the pathophysiology of neuropathic pain.A locus and mechanism of action for associative morphine toleranceOestrogen modulates cholecystokinin: opioid interactions in the nervous system.The role of spinal cholecystokinin in chronic pain states.Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E₂ in the spinal cord.Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.Pharmacological strategies in relieving neuropathic pain.Cholecystokinin antagonists--a toxicologic perspective.Cholecystokinin receptors mediate tolerance to the analgesic effect of TENS in arthritic rats.Recent advances in the physiology and pharmacology of pain: plasticity and its implications for clinical analgesia.Exploring neuroinflammation as a potential avenue to improve the clinical efficacy of opioids.NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System.Inhibition of KCC2 in mouse spinal cord neurons leads to hypersensitivity to thermal stimulationCCK in cerebral cortex and at the spinal level.Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons.Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine.Antidepressant-like effects of CCKB antagonists in mice: antagonism by naltrindole.Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain.Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammationSmall synthetic ligands of the cholecystokinin-B/gastrin receptor can mimic the function of endogenous peptide hormones.Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla.Morphine-induced in vivo release of spinal cholecystokinin is mediated by delta-opioid receptors--effect of peripheral axotomy.Opioid control of the in vitro release of cholecystokinin-like material from the rat substantia nigra.Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla.The "plantar test" apparatus (Ugo Basile Biological Apparatus), a controlled infrared noxious radiant heat stimulus for precise withdrawal latency measurement in the rat, as a tool for humans?Human pharmacokinetics and tolerability of L-365,260, a novel cholecystokinin-B antagonist.Pharmacological characterization of morphine-induced in vivo release of cholecystokinin in rat dorsal horn: effects of ion channel blockers.Reversal of electroacupuncture tolerance by CCK-8 antiserum: an electrophysiological study on pain-related neurons in nucleus parafascicularis of the rat.Analgesic Effects of 5-Alkyloxy-4-amino-2(5H)-furanones as Cholecystokinin-2 Antagonists.Lack of Analgesic Synergy of the Cholecystokinin Receptor Antagonist Proglumide and Spinal Cord Stimulation for the Treatment of Neuropathic Pain in Rats.Heteromerization of μ-opioid receptor and cholecystokinin B receptor through the third transmembrane domain of the μ-opioid receptor contributes to the anti-opioid effects of cholecystokinin octapeptide.
P2860
Q24552584-13F4E102-5C84-4BA0-973B-DB3FCFD14946Q24674564-7BDE1553-B514-4BF5-8381-C326CD85E5C0Q28572382-5B7F959D-BD0C-4D4A-973E-9989C07CC2CCQ28579164-C2AA404F-A4B7-4E20-8662-D32050E8985CQ33792380-AFA1D858-946F-48E3-A6DE-38DBA5D45E45Q34298025-9C375F35-0F3D-4B72-9F95-047EFBF702ABQ34409803-09ACE76F-81B5-4DB7-B8F1-AD4507A03F94Q34466681-01DB0DFA-3453-47C7-819B-18972AB7EDE7Q35016925-AA6DFFB5-14AF-45F9-86E8-954723F62D5DQ35082708-0616A8C3-D4E1-4188-B501-96CF81F7E257Q35104450-8D315790-3F86-4D8F-BD7F-8D4CCD44B8DAQ35104454-FF27B901-D020-4F99-9ED6-5DE12C224115Q35633022-ED36D26B-65A0-48C1-961A-3F0EA3592F51Q35708164-31B79FB4-D3CD-4810-92B5-DCBA9F886CF2Q35784044-F717FC30-27F5-465C-887F-67ED5A6F6329Q36071597-44CF4FD7-5D1E-4242-A12C-12C3F0E493FCQ37637839-9543BA21-C473-4787-A133-F3AAD4075844Q37979202-96B2F5BE-16EC-4892-A8A2-5A749747211BQ38066969-A7FABB95-094F-4257-9951-71F7CD6FBEECQ38974282-DB931700-5DA6-4536-B743-A2F08D631EA8Q39376489-AB785938-EF73-462A-B8CD-17AA8B38AB13Q40753253-992B799E-2CBB-4F44-AFD5-4F29564E8E84Q41531803-5F62C1D6-B83D-4CE0-B4C9-4377D3BB1B3BQ41878528-78370360-0ACB-4DEA-B941-A13338361714Q41973984-D7B8A2CC-A50A-4C9C-8740-4C18EFEA351FQ41992250-5B95A13F-6578-49BA-B289-CB16E8124846Q42118364-AE1FEA76-7B50-4F9B-ACEE-76D2A7D0BBAAQ43246236-3386DFAC-9386-47B1-84C5-8FFD15D54BDBQ43518009-D6C10899-21AB-424A-BB3B-5D6986947A1EQ43658586-D0C5FB3B-9170-4D9E-AD02-0F439BFA0377Q44330739-62055B87-22AC-4886-83C6-E6B322CB29F7Q44902293-18DBBAEE-DE64-42F4-84F5-498043F969D9Q50961070-C0D1F08B-C621-4B1E-BC05-96D21A3A657EQ51115263-A4EA7CB0-1053-4D64-B9B1-0E969A88771EQ51443898-8B2E5C1B-42B7-4551-BAEE-6557FCA1B03DQ51657500-97E3527A-DC4D-4488-AB4D-195B18EE1265Q53764103-BAF4E71F-E17C-441F-9A11-40284892E15BQ54091866-78FF6D6B-836B-45CD-B43C-08FA782D83C2Q55534471-B296545D-AA97-4179-854C-B181848BC5B5
P2860
The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
The selective CCK-B receptor a ...... morphine tolerance in the rat
@ast
The selective CCK-B receptor a ...... morphine tolerance in the rat
@en
The selective CCK-B receptor a ...... morphine tolerance in the rat
@nl
type
label
The selective CCK-B receptor a ...... morphine tolerance in the rat
@ast
The selective CCK-B receptor a ...... morphine tolerance in the rat
@en
The selective CCK-B receptor a ...... morphine tolerance in the rat
@nl
prefLabel
The selective CCK-B receptor a ...... morphine tolerance in the rat
@ast
The selective CCK-B receptor a ...... morphine tolerance in the rat
@en
The selective CCK-B receptor a ...... morphine tolerance in the rat
@nl
P2093
P1476
The selective CCK-B receptor a ...... morphine tolerance in the rat
@en
P2093
J Coughlan
M F O'Neill
S D Iversen
S J Kitchener
P356
10.1016/0014-2999(90)90129-T
P407
P577
1990-01-01T00:00:00Z